ARK GENOMIC REVOLUTION ETF ACC - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.25 USD | +6.00% |
|
0.00% | -19.99% |
| Current year | -19.99% |
Investment objective
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 50.38 USD | -3.02% | -5.85% | -31.90% | 8.97% | ||
| 2.02 USD | -7.76% | +14.12% | -79.41% | 5.76% | ||
| 56.22 USD | +0.99% | +9.87% | -10.19% | 5.34% | ||
| 22.76 USD | -0.61% | +0.13% | -36.42% | 4.88% | ||
| 0.8056 USD | -3.98% | +5.87% | -52.33% | 4.40% | ||
| 37.31 USD | -0.82% | -4.53% | -26.25% | 4.30% | ||
| 12.73 USD | -1.32% | +6.53% | -40.93% | 4.28% | ||
| 9.415 USD | -1.00% | +9.48% | -4.51% | 4.16% | ||
| 15.5 USD | +4.87% | +4.52% | +29.17% | 3.85% | ||
| 7.48 USD | +2.05% | +3.74% | -37.72% | 3.65% | ||
More news
In partnership with
| Date | Price | Change |
|---|
Other stock markets
Delayed Quote London S.E.
Last update May 13, 2024 at 07:00 pm IST
More quotesDescription
| US00214Q3020 | |
|---|---|
| Total Expense Ratio | 0.75% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider |
Features and characteristics
| Jurisdiction | |
| Date of creation |
01/04/2019
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 30/04/2024 )
| AuM (EUR) | 1,264 M€ |
|---|---|
| AuM 1M | 1,474 M€ |
| AuM 3 months | 1,530 M€ |
| AuM 6 months | 1,356 M€ |
| AuM 12 months | 1,699 M€ |
- Stock Market
- ETF
- 0CQL ETF
